Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy

Summary

The aim of this multicentre, prospective, double blind, placebo controlled, randomized pilot study is to investigate safety and tolerance of Epigallocatechin-Gallate (EGCG, the major polyphenol in green tea) in patients with muscular dystrophy of the Duchenne type. In a second step the investigators want to investigate the effect of EGCG on the course of the Duchenne condition.

Timeline

Start

2010-12-30

Primary completion

2018-09-06

Completion

2018-09-06

Drugs

Indications